Dimerization and signal transduction of the growth hormone receptor
- PMID: 12576487
- DOI: 10.1210/me.2002-0261
Dimerization and signal transduction of the growth hormone receptor
Abstract
GH binding to cell surface-localized GH receptors (GHRs) induces a conformational change of the dimerized receptors, resulting in activation of Janus kinase 2 and downstream signaling pathways. Interactions between the extracellular subdomain 2 of adjacent GHR polypeptides result in a 500-A2 contact interface, which has previously been suggested to stabilize the GH-(GHR)2 complex. In this study, we investigated further the role of subdomain 2 in GHR function. Amino acids that participate in (e.g. aspartic acid 152, tyrosine 200, or serine 201) or lie close to (e.g. asparagine 143 or cysteine 241) the contact interface were mutated in rabbit GHR. Surprisingly, none of the mutations affected GHR dimerization, as demonstrated by coimmunoprecipitation of a truncated, epitope-tagged GHR. However, signal transduction of GHR(D152H), GHR(Y200D), and GHR(S201K) mutants was precluded. More insight into the molecular mechanism of the signaling defect was obtained when we examined the effect of the mutations on the integrity of the GH-(GHR)2 complex in a protease-protection assay. In contrast to wild-type GHR, GHR(N143K), and GHR(C241S), the GHR(D152H), GHR(Y200D), and GHR(S201K) mutants were not protected against protease digestion by GH, indicating that a structural change is prevented. Together, we provide new evidence for a critical role of aspartic acid 152, tyrosine 200, and serine 201 of the GHR contact interface in the GH-induced conformational change to a signaling-competent complex rather than in GHR dimerization.
Similar articles
-
Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.Mol Endocrinol. 2007 Jul;21(7):1642-55. doi: 10.1210/me.2006-0458. Epub 2007 Apr 24. Mol Endocrinol. 2007. PMID: 17456794
-
A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.Mol Endocrinol. 2004 Dec;18(12):2981-96. doi: 10.1210/me.2004-0102. Epub 2004 Sep 2. Mol Endocrinol. 2004. PMID: 15345746
-
Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis.Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9858-63. doi: 10.1073/pnas.152294299. Epub 2002 Jul 8. Proc Natl Acad Sci U S A. 2002. PMID: 12105275 Free PMC article.
-
Receptor dimerization in GH and erythropoietin action--it takes two to tango, but how?Endocrinology. 2002 Jan;143(1):2-10. doi: 10.1210/endo.143.1.8607. Endocrinology. 2002. PMID: 11751584 Review.
-
The GH receptor and GH insensitivity.Growth Horm IGF Res. 1999 Jun;9 Suppl B:42-5; discussion 45-6. doi: 10.1016/s1096-6374(99)80080-x. Growth Horm IGF Res. 1999. PMID: 10549305 Review.
Cited by
-
Relationship between initial treatment effect of recombinant human growth hormone and exon 3 polymorphism of growth hormone receptor in Chinese children with growth hormone deficiency.Int J Clin Exp Med. 2015 May 15;8(5):7965-70. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221355 Free PMC article.
-
Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4alpha2 and HNF-4alpha8.Mol Endocrinol. 2008 Feb;22(2):485-500. doi: 10.1210/me.2007-0387. Epub 2007 Nov 8. Mol Endocrinol. 2008. PMID: 17991764 Free PMC article.
-
Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.Biochemistry. 2010 Jun 29;49(25):5117-33. doi: 10.1021/bi100041f. Biochemistry. 2010. PMID: 20496919 Free PMC article.
-
Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.Front Endocrinol (Lausanne). 2020 Nov 18;11:597573. doi: 10.3389/fendo.2020.597573. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33312162 Free PMC article. Review.
-
Rational design of competitive prolactin/growth hormone receptor antagonists.J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):105-17. doi: 10.1007/s10911-008-9066-8. Epub 2008 Jan 25. J Mammary Gland Biol Neoplasia. 2008. PMID: 18219565 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources